MX366496B - Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. - Google Patents
Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.Info
- Publication number
- MX366496B MX366496B MX2014010152A MX2014010152A MX366496B MX 366496 B MX366496 B MX 366496B MX 2014010152 A MX2014010152 A MX 2014010152A MX 2014010152 A MX2014010152 A MX 2014010152A MX 366496 B MX366496 B MX 366496B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- eslicarbazepine acetate
- pharmaceutical compositions
- present disclosure
- preparing pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente descripción se refiere al tratamiento de diversas enfermedades y condiciones con acetato de eslicarbazepina. La presente descripción también se refiere al uso del acetato de eslicarbazepina en un método para reducir o disminuir los ataques epilépticos en un paciente. La presente descripción también se refiere a. un método para incrementar la exposición a la eslicarbazepina en un paciente. La presente descripción también se refiere a un método para preparar una composición farmacéutica que comprende acetato de eslicarbazepina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2005/002357 WO2006120501A1 (en) | 2005-05-06 | 2005-05-06 | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX366496B true MX366496B (es) | 2019-07-11 |
Family
ID=35335795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014010152A MX366496B (es) | 2005-05-06 | 2005-05-06 | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. |
| MX2007013882A MX2007013882A (es) | 2005-05-06 | 2005-05-06 | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007013882A MX2007013882A (es) | 2005-05-06 | 2005-05-06 | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU2005331690C1 (es) |
| BR (1) | BRPI0520258A2 (es) |
| CA (1) | CA2607427C (es) |
| MX (2) | MX366496B (es) |
| WO (1) | WO2006120501A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121363A1 (en) * | 2005-05-06 | 2006-11-16 | Portela & C.A., S.A. | Eslicarbazepine acetate and methods of use |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB0700773D0 (en) * | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| AU2007346591A1 (en) | 2007-02-07 | 2008-08-14 | Gosforth Centre (Holdings) Pty Ltd | Treatment of ADHD |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| WO2010015029A1 (en) * | 2008-08-06 | 2010-02-11 | Gosforth Centre (Holdings) Pty Ltd | Compositions and methods for treating psychiatric disorders |
| WO2011014084A1 (en) | 2009-07-27 | 2011-02-03 | Bial - Portela & Ca., S.A. | Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| JP6133786B2 (ja) * | 2010-12-31 | 2017-05-24 | ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ | エスリカルバゼピンアセテート含有顆粒 |
| EP2747770A1 (en) * | 2011-08-26 | 2014-07-02 | BIAL - Portela & Cª S.A. | Treatments involving eslicarbazepine acetate or eslicarbazepine |
| GB201306095D0 (en) * | 2013-04-04 | 2013-05-22 | Bial Portela & Ca Sa | New treatments |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
| TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
-
2005
- 2005-05-06 MX MX2014010152A patent/MX366496B/es unknown
- 2005-05-06 MX MX2007013882A patent/MX2007013882A/es active IP Right Grant
- 2005-05-06 WO PCT/IB2005/002357 patent/WO2006120501A1/en active Application Filing
- 2005-05-06 AU AU2005331690A patent/AU2005331690C1/en active Active
- 2005-05-06 CA CA2607427A patent/CA2607427C/en active Active
- 2005-05-06 BR BRPI0520258-2A patent/BRPI0520258A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0520258A2 (pt) | 2009-09-15 |
| AU2005331690A1 (en) | 2006-11-16 |
| AU2005331690B2 (en) | 2012-09-20 |
| AU2005331690C1 (en) | 2013-01-17 |
| CA2607427C (en) | 2015-11-24 |
| CA2607427A1 (en) | 2006-11-16 |
| WO2006120501A1 (en) | 2006-11-16 |
| MX2007013882A (es) | 2008-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006093348A3 (en) | Method and composition for treating peripheral vascular diseases | |
| ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
| MX2010004494A (es) | Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios. | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| MX2012003555A (es) | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. | |
| ZA200810194B (en) | "use of arylcarboxylic acid biphenylmides for seed treatment" | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| SI2176252T1 (sl) | 2,3-dihidrobenzo(1,4)dioksin-2-ilmetilni derivati kot alfa2C antagonisti za uporabo v zdravljenju bolezni perifernega in centralnega živčnega sistema | |
| TW200606162A (en) | Pyrazolopyridine derivatives | |
| WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
| EP2217238A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA | |
| UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
| IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
| AR055939A1 (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso | |
| SG141358A1 (en) | Treatment of psychiatric patients with reduced heptaic function with paliperidone | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| MX366496B (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. | |
| MX2012007234A (es) | Nanocristales de monohidrato de calciprotiol. | |
| IL186022A0 (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
| WO2010085799A9 (en) | Compositions and method for the treatment of parkinson's disease | |
| EP2716285A3 (en) | New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss | |
| GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease | |
| SG10201809506TA (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
| SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
| WO2010028130A3 (en) | Antidepressant compounds |